Poly(ADP-ribose) polymerase (PARP) inhibition and cytoprotection using novel, potent isoindolinone-inhibitors of PARP

被引：0
|
作者：
Baloglu, E [1 ]
Jagtap, P [1 ]
Mabley, JG [1 ]
Salzman, AL [1 ]
Szabo, C [1 ]
Southan, GJ [1 ]
机构：
[1] Inotek Pharmaceut Crop, Beverly, MA 01915 USA
来源：
FASEB JOURNAL | 2003年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1360 / A1360
页数：1
相关论文
共 50 条
  • [1] Design and synthesis of novel, potent poly(ADP-ribose) polymerase (PARP) inhibitors.
    Xu, WZ
    Liu, Q
    Chen, JA
    Ko, YS
    Li, JH
    Lu, M
    Tran, S
    Zhang, J
    Kalish, V
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U53 - U53
  • [2] New inhibitors of poly(ADP-ribose) polymerase (PARP)
    Peukert, S
    Schwahn, U
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (11) : 1531 - 1551
  • [3] Imidazoquinolinone, Imidazopyridine, and Isoquinolindione Derivatives as Novel and Potent Inhibitors of the Poly(ADP-ribose) Polymerase (PARP): A Comparison with Standard PARP Inhibitors
    Eltze, Tobias
    Boer, Rainer
    Wagner, Thomas
    Weinbrenner, Steffen
    McDonald, Michelle C.
    Thiemermann, Christoph
    Buerkle, Alexander
    Klein, Thomas
    [J]. MOLECULAR PHARMACOLOGY, 2008, 74 (06) : 1587 - 1598
  • [4] NOVEL POTENT INHIBITORS OF THE DNA-REPAIR ENZYME POLY(ADP-RIBOSE)POLYMERASE (PARP)
    GRIFFIN, RJ
    PEMBERTON, LC
    RHODES, D
    BLEASDALE, C
    BOWMAN, K
    CALVERT, AH
    CURTIN, NJ
    DURKACZ, BW
    NEWELL, DR
    PORTEOUS, JK
    GOLDING, BT
    [J]. ANTI-CANCER DRUG DESIGN, 1995, 10 (06): : 507 - 514
  • [5] Development of Poly (ADP-Ribose)Polymerase (PARP) Inhibitors in Oncology
    Jones, Philip
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 229 - +
  • [6] Mechanism of radiosensitization by inhibitors of poly(ADP-ribose) polymerase (PARP)
    Hegan, Denise C.
    Glazer, Peter M.
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
    Liu, Chia-Hao
    Chang, Yi
    Wang, Peng-Hui
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2017, 56 (05): : 713 - 714
  • [8] Mechanism of Radiosensitization by Inhibitors of Poly (ADP-Ribose) Polymerase (PARP)
    Glazer, P. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S87 - S88
  • [9] Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
    Jannetti, Stephen A.
    Zeglis, Brian M.
    Zalutsky, Michael R.
    Reiner, Thomas
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] Potentiation of temozolomide and topotecan growth inhibition by novel potent benzimidazole poly(ADP-ribose) polymerase (PARP) inhibitors.
    Curtin, NJ
    Kyle, S
    Wang, LZ
    Durkacz, BW
    White, AJ
    Srinivasan, S
    Griffin, RJ
    Golding, BTG
    Newell, DR
    Calvert, AH
    Maegley, K
    Hostomsky, Z
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 : 3834S - 3834S
12345